ロード中...

Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome

PURPOSE: The efficacy of levoketoconazole in treating hypercortisolism was demonstrated in an open-label phase 3 study (SONICS) of adults with endogenous Cushing’s syndrome (CS) and baseline mean urinary free cortisol (mUFC) ≥  1.5× ULN. Clinical signs and symptoms and patient-reported outcomes from...

詳細記述

保存先:
書誌詳細
出版年:Pituitary
主要な著者: Geer, Eliza B., Salvatori, Roberto, Elenkova, Atanaska, Fleseriu, Maria, Pivonello, Rosario, Witek, Przemyslaw, Feelders, Richard A., Bex, Marie, Borresen, Stina W., Puglisi, Soraya, Biller, Beverly M. K., Cohen, Fredric, Pecori Giraldi, Francesca
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864823/
https://ncbi.nlm.nih.gov/pubmed/33216275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-020-01103-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!